Therefore, septin4-K174R (mimicking deacetylation via SIRT2) may be a new target for alleviating renal injury in hypertension (47), which may help design precise therapeutic regimens and develop targeted drugs in the future. The gene discussed is SIRT2; the disease is hypertensive disorder.